Blog - Page 2426 of 5624

TuesdayMar 07, 2017 3:24 pm

Ring Energy, Inc. (REI) Rebounds from Lows and Increases Production

Oil and gas company stocks have taken a beating as oil prices have tumbled from a peak of over $100 in 2014 to around $50 a barrel today. This fall in prices crippled many exploration and production companies. Down from its peak of nearly $20 per share in 2014, Ring Energy, Inc. (NYSE MKT: REI) is still in a better position than most. Unlike other drillers, Ring Energy isn’t highly leveraged and has comparatively low production costs. Ring Energy has stated that it could operate profitably under $60 per barrel, and the majority of the company's crude production is based…

TuesdayMar 07, 2017 10:13 am

SeeThruEquity Issues Update on ChineseInvestors.com (CIIX), Increases Price Target to $3.75

Less than two weeks after making a presentation at the SeeThruEquity Conference in Miami Beach, SeeThruEquity increased its price target for ChineseInvestors.com (OTCQB: CIIX) to $3.75. The previous price target for CIIX, issued in October 2016, was $2.05. SeeThruEquity delivers unbiased and unpaid for equity research for publicly traded companies with market capitalizations of less than $1 billion. The increased target price reflects the added potential from legal cannabis initiatives taken by ChineseInvestors.com. Though in the early stages of penetrating the legal cannabis market, ChineseInvestors.com has demonstrated prior success with its profitable investment in Medicine Man Technologies, generating $2.3 million…

MondayMar 06, 2017 1:32 pm

The Female Health Company / Veru Healthcare (NASDAQ: FHCO) is “One to Watch”

The Female Health Company / Veru Healthcare (NASDAQ:FHCO) has established for itself an extremely robust footing in the global public health sector via its hormone-free, latex-free FC2 Female Condom, the only FDA-approved female condom in a market forecast to deliver nine percent plus CAGR over the next five years. The Americas, EMEA and APAC regions alone amount to roughly half a billion plus in revenues already, according to Technavio, and while the Americas’ female condom market accounts for nearly half of the global sum, China and India will most likely drive APAC to out-pace all other regions in terms of…

MondayMar 06, 2017 10:51 am

InMed Pharmaceuticals, Inc. (IMLFF) is “One to Watch”

InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver. Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases,…

FridayMar 03, 2017 4:29 pm

ORHub, Inc. (ORHB) Provides Cloud Based Cure for High Health Care Costs

Health care costs in the U.S. have been rising rapidly over the decades and data provided by the Kaiser Family Foundation (http://dtn.fm/Xfs0F) show the extent of that rise. In 1960, total national expenditure on health care was $27.2 billion, amounting to 5 percent of GDP. In 2015, it had climbed to $3.2 trillion, increasing by an astounding 11,785 percent to 17.8 percent of National Income (GDP). The causes are diverse: a combination of factors that include greater demand for health services and a population that is living longer. But the solutions have been less obvious. Now, ORHub, Inc. (OTC: ORHB)…

FridayMar 03, 2017 2:02 pm

MediWound (NASDAQ: MDWD) to Extend Label for Pineapple Drug to Larger Burns

When Christopher Columbus introduced the pineapple to Europe in the late fifteenth century, he undoubtedly would have had no idea that extracts from the plant could be used to treat severe thermal burns. Yet, 500 years later, a next-generation proteolytic enzyme platform for wound debridement, NexoBrid, derived from pineapples, has been developed by MediWound Ltd. (NASDAQ: MDWD). Now, positive results from a Phase II study evaluating NexoBrid will be used to support a request to the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to extend the label for NexoBrid to larger burns. The painstaking research undertaken…

ThursdayMar 02, 2017 4:40 pm

India Globalization Capital, Inc. (NYSE MKT: IGC) Targets Cannabis-Based Pharmaceuticals

India Globalization Capital, Inc. (NYSE MKT: IGC) is a company in transition, now targeting pharmaceutical development in the U.S., while curtailing other businesses such as electronics trading in Hong Kong. IGC long-term plans are to establish and extend its development of phytocannabinoid-based pharmaceutical products to treat diseases such as epilepsy and cachexia. The company expects to file more patents and develop additional intellectual property in the health care industry. In the U.S., IGC develops phytocannabinoid-based treatments for epilepsy, seizures and cachexia. The goal in 2017, per CEO Ram Mukunda, is for the company to expand its cannabis-based portfolio, indicating that…

ThursdayMar 02, 2017 2:50 pm

Pressure BioSciences, Inc. (PBIO) Receives New Instrument Award from Corporate America News Magazine

On Wednesday, Pressure BioSciences, Inc. (OTCQB: PBIO) announced that it has received the award for 'Best New Instrument For Sample Preparation 2017' from Corporate America News (http://dtn.fm/CAg47) for its Barocycler 2320Extreme. The unit is the most recent product added to PBIO’s Barocycler line. It is a smaller device designed for preparing protein samples for review. It is sold to the life science market, which is valued at roughly $6 billion, according to industry data. Pressure BioSciences, Inc. develops and sells laboratory instrumentation. It manufactures products in static and alternating pressure. The company says it has installed more than 250 of…

ThursdayMar 02, 2017 2:05 pm

Axim Biotechnologies (AXIM) Boosts Billion-Dollar Brand Portfolio with Launch of CanChew Plus™

Now that production of its next generation award-winning controlled-release cannabidiol (CBD) functional chewing gum, CanChew Plus™, has kicked off, Axim Biotechnologies (OTCQB: AXIM) has boosted its diverse billion-dollar product portfolio with another strong growth brand. With so many golden eggs in its brand basket, the company is expecting strong top line growth in the near future. Current revenue projections show AXIM could soon earn the rarified rank of unicorn. AXIM is looking ahead to a bright future with an uplisting to either the NYSE or NASDAQ. The company’s strong sales projections are built on a number of factors. The company’s…

ThursdayMar 02, 2017 10:13 am

SinglePoint, Inc. (SING) Banking on Greener Pastures

SinglePoint, Inc. (OTC: SING) has a considerable stake in the state of the legal cannabis industry. Among other things, SinglePoint is a holding company for SingleSeed, a company that provides payment services, solutions, and support for the cannabis industry. Working in tandem, SinglePoint and SingleSeed share resources and offer non-cash payment solutions, such as: Pay by Text solutions that allow customers to pay for products using their mobile phones; point of sale terminals that provide customers the convenience of using debit/credit cards right at checkout; text mobile marketing solutions; and text message marketing. SingleSeed exists to inform and educate shopkeepers…

Site Search

Company Search